Child obesity;Obesidad infantil

Revista Espanola de Obesidad

Volumn 3, Issue 1, 2005, Pages 26-39

  Azcona San Julian C ^a   Romero Montero, A ^a   Bastero Minon P ^a   Santamaria Martinez E ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADOLESCENT DISEASE; CALORIC INTAKE; CARDIOVASCULAR RISK; CHILD BEHAVIOR; CHILDHOOD DISEASE; CLINICAL PRACTICE; DIABETES MELLITUS; DIETITIAN; EATING HABIT; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; GALLBLADDER DISEASE; GENETIC TRAIT; HEALTH PROGRAM; HUMAN; HYPERTENSION; LIFESTYLE; LIPID METABOLISM; LONG TERM CARE; NEUROENDOCRINOLOGY; NURSE; OBESITY; PEDIATRICIAN; PSYCHIATRIST; PSYCHOLOGIST; REVIEW; RISK FACTOR; WEIGHT REDUCTION;

EID: 33646858806     PISSN: 16966112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Kimm SYS, Obarzanek E. Childhood Obesity: A new pandemic of the new millenium. Pediatrics 2002; 110: 1003-7.
2. Dietz WH, Bellizzi MC. Assessment of childhood and adolescent obesity: results from an International Obesity Task Force workshop. Am J Clin Nutr 1999; 70: 117S-75S.
3. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obes Rev 2003; 4: 195-200.
4. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-32.
5. Serra L, Ribas L, Aranceta J, Pérez C, Saavedra P, Pena L. Childhood and adolescent obesity in Spain. Results of the enKid study (1998-2000). Med Clin (Barc) 2003; 121: 725-32.
6. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes 2004; 28: 34-8.
7. Reilly JJ, Metheven E, McDowell ZC, Hacking B, Alexander D, Stewart L, et al. Health consequences of obesity. Arch Dis Child 2003; 88: 748-52.
8. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become obese adults? A review of the literature. Prev Med 1993; 22: 167-77.
9. Whitaker RC, Wright JA, Pape MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1991; 337: 869-73.
10. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-3.
11. Frühbeck G, Raggio S, Azcona C, Gómez-Ambrosi J, Salvador J. Childhood Obesity: a further step needed (http://bmj.com/cgi/eletters/322/7282/ 326).
12. Prentice AM. Body mass index standards for children. BMJ 1998; 317: 1401-2.
13. Moran R. Evaluation and treatment of childhood obesity. Am Fam Physician 1999; 59: 861-8.
14. Legido A, Sarría A, Bueno M, Garagorri J, Fleta J, Ramos F, et al. Relatioship of body fat distribution to metabolic complications in obese prepubertal boys: Gender related differences. Acta Paediatr Scand 1989; 78: 440-6.
15. Stunkard AJ, Sorensen TIA, Hanis G, Teasdale TW, Chakraborty R, Schyll WJ, et al. An adoption study of human obesity. N Engl J Med 1986; 314: 193-8.
16. Bodhurta JN, Mosteller M, Hewitt JK, Nance WE, Eaves LJ, Moskowitz WB, et al. Genetic analysis of anthropometric measures in 11 year-old twins. Pediatr Res 1990; 28: 1-4.
17. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1995; 372: 425-32.
18. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398-401.
19. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19: 155-7.
20. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocorin-4 receptor results in obesity in mice. Cell 1997; 88: 131-41.
21. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271-9.
22. Widén E, Letho M, Kanninen T, Waltson J, Shuldiner AR, Groop LC. Association of a polymorphism in the (3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Eng J Med 1995; 333: 348-51.
23. Waltson J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the (3-adrenergic receptor gene. N Engl J Med 1995; 333: 343-47.
24. Garenc C, Perusse L, Chagnon YC, Rankinen T, Gagnon J, Borecki IB, et al. Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study. Obes Res 2003; 11: 612-8.
25. Dalgaard LT, Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 2001; 44: 946-65.
26. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. Association of the TNF-alpha-308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002; 10: 401-7.
27. Akabayasi A, Levin N, Paez X, Alexander JT, Leibowitz SF. Hypothalamic neuropeptide Y and its gene expression: relation to light/dark cycle and circulating corticosterone. Mol Cell Neurosci 1994; 5: 210-8.
28. Dietz WH, Gortmarker SL. Do we fatten our children at the television set? Television viewing and obesity in children and adolescents. Pediatrics 1985; 75: 807-12
29. Proctor MH, Moore LL, Gao D, Cupples LA, Bradlee ML, Hood MY, et al. Television viewing and change in body fat from preschool to early adolescence: The Framingham Children's Study. Int J Obes 2003; 27: 827-33.
30. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-71.
31. O'Rahilly S. Leptin: Defining its role in humans by the clinical study of genetics disorders. Nutr Rev 2002; 60: 30-4.
32. Bray GA, Greenway FL. Current and potential drugs for treatment for obesity. Endocr Rev 1999; 20: 805-75.
33. Cummings DE, Purnell JQ, Frayo RS, Schimidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin level suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-9.
34. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-4.
35. Asawaka A, Inui A, Kaga T, Yuzuriha H, Nagata T, Uneno N, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337-45.
36. White WO, Schwartz GJ, Moran TH. Role of endogenous CCK in the inhibition of gastric emptying by peptone and Intralipid in rats. Regul Pept 2000; 88: 47-53.
37. Radetti G, Bozzola M, Pasquino B, Paganini C, Aglialoro A, Livieri C, et al. Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children. Metabolism 1998; 47: 1490-3.
38. Stichel H, I'Allemand D, Grüters A. Thyroid Function and Obesity in Children and Adolescents. Horm Res 2000; 54: 14-9.
39. Dietz WH, Bandini LG, Schoeller DA. Estimates of metabolic rate in obese and non obese adolescents. J Pediatr 1991; 118: 17333-6.
40. Goran MI. Energy metabolism and obesity. Med Clin North Am 2000; 84: 347-62.
41. Tershakovec AM, Kuppler KM, Zemel B, Stallings VA. Age, sex, ethnicity body composition, and resting energy expenditure of obese African American and white children and adolescents. Am J Clin Nutr 2002; 75: 867-71.
42. Ekelund U, Aman J, Yngve, Renman C, Westerter K, Sjöström M. Physical activity but not energy expenditure is reduced in obese adolescents: a case-control study. Am J Clin Nutr 2002; 76: 935-41.
43. Sobradillo B, Aguirre A, Aresti U, Bilbao C, Fernández-Ramos C, Lizárraga A, et al. Curvas y tablas de crecimiento (estudio longitudinal y transversal). Fundación Faustino Orbegozo Eizaguirre, 2004.
44. Moreno LA, Sarría A, Mur M, Lázaro A, Bueno M. Body fat distribution in children of families with familial combined hyperlipidemia. Nutr Metab Cardiovasc Dis 1994; 83: 941-5.
45. Westrate JA, Deurenberg P, Tinteren H. Indices of body fat distribution and adiposity in Dutch children from birth to 18 years of age. Int J Obes 1989; 13: 465-77.
46. Moreno LA, Fleta J, Mur L, Feja C, Sarría A, Bueno M. Indices of body fat distribution in spanish children aged 4,0 to 14,9 years. J Paediatr Gastroenterol Nutr 1997; 25: 175-81.
47. Fuller NJ, Jebb SA, Laskey MA, Coward WA, Elia M. Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci (Colch) 1992; 82: 687-93.
48. Dewit O, Fuller NJ, Fewtrell MS, Elia M, Wells JCK. Whole body air displacement plethysmography compared for body composition analysis. Arch Dis Child 2000; 82: 159-64.
49. Feldman W, Feldman E, Goodman JT. Culture versus biology: Children's attitudes towards thinness and fitness. Pediatrics 1988; 81: 1904
50. Staffieri JR. A study of social stereotype of body image in children. J Pers Soc Psychol 1961; 7: 101-4.
51. Willis DE, McCoy B, Berman M. The effect of a weight management program on self esteem and body image in obese youth. Am J Dis Child 1990; 144: 417.
52. Morgan CM, Yanovski SZ, Nguyen TT, McDuffie J, Sebring NG, Jorge MR, et al. Loss of control overeating, adiposity, and psychopathology in overweight children. Int J Eat Disord 2002; 31: 430-431.
53. Sheslow D, Hassink S, Wallace W, DeLancey E. The relationship between self-esteem and depression in obese children. Ann N Y Acad Sci 1993; 699: 289-91.
54. Ramos F, Baglivo HP, Ramírez AJ, Sánchez R. The metabolic syndrome and related cardiovascular risk. Curr Hypertens Rep 2001; 3: 100-6.
55. Woo KS, Chook P, Yu CW, Sung RYT, Qiao M, Leung SSF, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation, 2004; 109: 1981-6.
56. Devlin MJ, Yanovski SZ, Wilson GT. Obesity: what mental health professionals need to know. Am J Psychiatry 2000; 157: 854-66.
57. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, et al. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 147: 77-84.
58. NIH. Consensus development conference draft statement on gastrointestinal surgery for severe obesity. Obes Surg 1991; 1: 257-65.